Bosh sahifa300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Yopilish kursi
16,79 ¥
Kunlik diapazon
16,65 ¥ - 16,90 ¥
Yillik diapazon
13,10 ¥ - 21,39 ¥
Bozor kapitalizatsiyasi
18,38 mlrd CNY
Oʻrtacha hajm
19,63 mln
Narx/foyda
336,56
Dividend daromadliligi
0,54%
Asosiy maydon
SHE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 746,86 mln | -0,47% |
Joriy xarajat | 545,63 mln | 14,03% |
Sof foyda | 15,10 mln | -86,43% |
Sof foyda marjasi | 2,02 | -86,38% |
Har bir ulushga tushum | — | — |
EBITDA | 41,21 mln | -73,10% |
Amaldagi soliq stavkasi | 156,17% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,44 mlrd | 221,80% |
Jami aktivlari | 14,13 mlrd | -2,19% |
Jami passivlari | 4,53 mlrd | -7,75% |
Umumiy kapital | 9,60 mlrd | — |
Tarqatilgan aksiyalar | 1,12 mlrd | — |
Narxi/balansdagi bahosi | 1,95 | — |
Aktivlardan daromad | -1,00% | — |
Kapitaldan daromad | -1,23% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 15,10 mln | -86,43% |
Operatsiyalardan naqd pul | 121,90 mln | -8,83% |
Sarmoyadan naqd pul | 62,96 mln | -23,54% |
Moliyadan naqd pul | -187,09 mln | 75,28% |
Naqd pulning sof oʻzgarishi | -2,37 mln | 99,56% |
Boʻsh pul | 2,56 mlrd | 636,57% |
Haqida
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Tashkil etilgan
8-sen, 1992
Sayt
Xodimlar soni
1 913
